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ABSTRACT 
The present study aimed at elucidating the effect of local pH in the extracellular microenvironment 
of tissue-engineered (TE) constructs on bone cell functions pertinent to new tissue formation. To this 
aim, we evaluated the osteogenicity process associated with bone constructs prepared from human 
Bone marrow-derived mesenchymal stem cells (hBMSC) combined with 45S5 bioactive glass (BG), a 
material that induces alkalinization of the external medium. The pH measured in cell-containing BG 
constructs was around 8.0, that is, 0.5 U more alkaline than that in two other cell-containing 
materials (hydroxyapatite/tricalcium phosphate [HA/TCP] and coral) constructs tested. When 
implanted ectopically in mice, there was no de novo bone tissue in the BG cell-containing constructs, 
in contrast to results obtained with either HA/TCP or coral ceramics, which consistently promoted 
the formation of ectopic bone. In addition, the implanted 50:50 composites of both HA/TCP:BG and 
coral:BG constructs, which displayed a pH of around 7.8, promoted 20–30-fold less amount of bone 
tissue. Interestingly, hBMSC viability in BG constructs was not affected compared with the other two 
types of material constructs tested both in vitro and in vivo. Osteogenic differentiation (specifically, 
the alkaline phosphatase [ALP] activity and gene expression of RUNX2, ALP, and BSP) was not 
affected when hBMSC were maintained in moderate alkaline pH (≤7.90) external milieu in vitro, but 
was dramatically inhibited at higher pH values. The formation of mineralized nodules in the 
extracellular matrix of hBMSC was fully inhibited at alkaline (>7.54) pH values. Most importantly, 
there is a pH range (specifically, 7.9–8.27) at which hBMSC proliferation was not affected, but the 
osteogenic differentiation of these cells was inhibited. Altogether, these findings provided evidence 
that excessive alkalinization in the microenvironment of TE constructs (resulting, for example, from 
material degradation) affects adversely the osteogenic differentiation of osteoprogenitor cells. 
 
Introduction 
Bone marrow-derived mesenchymal stem cells (BMSC), which are able of osteodifferentiation and, 
thus, promote bone formation,1,2 support the repair and/or regeneration of osseous defects when 
they are distributed in appropriate biomaterial scaffolds.3–6 Such scaffolds are designed as 
temporary matrices for supporting new tissue development and bone growth. The ideal scaffolds 
should provide a framework, as well as a specific environment, for cell attachment, proliferation, 
differentiation, and formation of tissue-specific extracellular matrix (ECM).7 Such scaffolds should 
also be absorbable with rates of resorption that are commensurate to those of bone formation. 
Understanding, and controlling, pertinent cell functions by modulating the local engineered 
extracellular environment is a critical issue in the development of suitable material scaffolds for bone 
tissue engineering (TE) applications. In this respect, an extensive number of studies have reported 
the significant effect of scaffold properties, such as chemical composition, surface topography and 
chemistry, pore size, porosity, and specimen size on cell functions and, therefore, on the osteogenic 
outcome of engineered scaffolds.8,9 However, the microenvironment or milieu where the cells 
reside has received little attention. This issue is even more critical because such local environments 
can be affected by the resorption of the scaffold material, especially by solutes arising from the 
material dissolution and by concomitant pH changes.10 
Among the biomaterials tested for bone TE application to date, calcium-based materials, such as 
hydroxyapatite (HA), tricalcium phosphate (TCP), calcium carbonate (coral) ceramics, and bioactive 
glass (BG), are the most promising ones. These calcium-containing materials are appropriate for 
bone-related applications because of similarities of their chemical and mechanical properties with 
the mineral phase of natural bone. In addition, these materials are considered osteoconductive and 
bioactive because of both their bonding capacity to surrounding osseous tissue and the ability to 
promote new bone tissue formation.11,12 When combined with human BMSC (hBMSC), HA, TCP, 
biphasic HA/TCP, and coral ceramics induced de novo bone tissue in the subcutis of 
immunocompromised mice.13–18 In contrast, and despite the expanding application of BG (such as 
45S5 BG) and glass ceramics as bone substitutes,19 information regarding the osteogenic potential of 
hBMSC in combination with BG scaffolds is strikingly lacking in the bone TE field. 
Whereas the biocompatibility and osteoconductivity of BG has long been established,19,20 such 
material is also known for the release of ion dissolution products as well as for inducing alkalinization 
of the external medium upon exposure to either physiological solutions or body fluids.21–23 Changes 
in the extracellular fluid pH of the local biological microenvironment can profoundly affect cell 
metabolism and function22,24 as well as the processes of bone tissue formation and 
mineralization.25 Chronic systemic acidosis promotes bone resorption, whereas alkalosis promotes 
bone formation by stimulating pertinent osteoblast functions.26–28 More recently, Shen et al. 
reported the beneficial role of local alkalinization mediated by borosilicate BG on the viability of 
preosteoblasts.10 However, the positive or negative effect of pH in cell constructs has never been 
investigated in the bone TE field. This aspect is crucial since the implanted hBMSC are in a confined 
space within tissue constructs and are, therefore, especially vulnerable to chemical changes within 
the local biological microenvironment. 
For these reasons, the present study focused on examining the impact of pH, specifically, 
alkalinization, in the engineered extracellular microenvironment on hBMSC-mediated osteogenesis. 
To this aim, we evaluated both in vitro and in vivo, the osteogenicity of bone constructs prepared 
from hBMSC combined with 45S5 BG (a material that induces alkalinization of the external medium) 
in comparison with results obtained using two other clinically available, calcium-based scaffolds, 
specifically, biphasic HA/TCP and coral ceramics. Biomaterial granules of equivalent size (∼400 μm in 
diameter), similar construct preparation, and similar implant dimensions were used to ensure an 
equivalent material surface area (at the cell scale) as well as an equivalent intergranule volume 
available to cells within three-dimensional (3D) material constructs. The in vivo osteogenic outcomes 
of TE constructs were correlated with their local pH. In addition, the in vitro effect of pH on the 
proliferative and osteogenic differentiation of hBMSC was determined. 
 
Materials and Methods 
Material scaffolds  
Three calcium-based materials in the form of granules were studied. These granules differed in terms 
of their chemical composition as well as shape and surface area, but all had sizes in the 300–690 μm 
range. The biphasic calcium phosphate granules (HA/TCP), composed of 60% HA and 40% TCP, were 
produced using the spray drying process followed by high temperature calcination; these granules 
(300–570 μm; mean size: 417 μm) were donated by Zimmer, Inc. Natural coral granules (Porites 
species; Biocoral®) consisted of 99% calcium carbonate in the form of aragonite29,30; these 
materials (300–600 μm; mean size: 426 μm) were donated by Inoteb, Inc. The nonporous 45S5 
silicate BG (designated BG hereafter) granules of nominal 45% SiO2, 24.5% CaO, 24.5% Na2O, and 6% 
P2O5 in wt% composition (300–690 μm; mean size: 457 μm) were donated by Noraker and were 
preconditioned in laboratory-made simulated body fluid (SBF) as recommended by the supplier. 
Briefly, BG granules were immersed in a SBF solution (0.1 g of BG per mL of solution) and were 
maintained under mild stirring by rotation at 37°C for 4 weeks. The SBF solution was renewed twice a 
week. Then, granules were rinsed with double distilled water and dried before sterilization. SBF 
pretreatment promotes the formation of a bone-like carbonated HA (cHA) layer as well as calcite on 
its surface.31–34 
The surface of the granules used in the present study was examined using scanning electronic 
microscopy (SEM) (SEM-FEG, JEOL JSM-6500F). The specific surface areas were determined according 
to the BET method 8 points using N2 adsorption isotherms (Micromeritics ASAP 2010) as previously 
described.35 The particle size distribution was determined by using a laser diffractometer with a 
Hydro 2000S module (Mastersizer 2000 from Malvern Instruments Ltd.). 
hBMSC isolation, expansion, and labeling with Luc gene  
hBMSC were harvested from bone marrow obtained as discarded tissue (intramedullary reamings) 
from four female patients and one male patient 17, 31, 31, 49, and 63 years old (mean age: 
38.8±17.7 years) who were operated for traumatic orthopedic indications in the absence of any 
detected chronic pathologies (such as diabetes, cancer, arthritis) at the Lariboisiere Hospital (Paris, 
France). The tissues were collected with the respective patient's consent in agreement with 
Lariboisière Hospital (Paris, France) regulations. The hBMSC were isolated using a procedure adapted 
from literature reports.1 Briefly, cells were harvested by gently flushing the collected bone marrow 
samples through decreasing (from 16G to 21G) needle sizes. These cells were then cultured in a 
standard cell culture medium, that is, alpha-modified minimum essential medium (αMEM) containing 
10% fetal calf serum (PAA Laboratories) and 1% of an antibiotic/antimycotic solution (PAA 
Laboratories), in a humidified, 37°C, 5% CO2/95% air environment. When the hBMSC reached 60–
70% confluence, they were trypsinized and subcultured at a density of 1000–5000 cells cm2. HBMSC 
obtained from the five aforementioned patients were pooled at the same density, expanded, and 
used up to passage 4–5 for the experiments described in the sections that follow. 
Genetically modified hBMSC were obtained following their transduction with a lentiviral vector 
encoding firefly luciferase (pTMLW-MND-Luc; Vector platform/INSERM U876) as previously 
described.36 Transduced cells (designated as LuchBMSC hereafter) were expanded and used to 
monitor the hBMSC viability in cell-containing constructs both in vitro and in vivo. 
Preparation of cell-containing constructs  
For all cell-related experiments in the present study, aliquots of 40 mg of granules of the materials 
tested were sterilized by autoclaving, then sequentially rinsed twice in phosphate buffer saline (PBS), 
and also rinsed once in a serum-free αMEM (Sigma-Aldrich) cell culture medium. 
Aliquots of hBMSC (or LuchBMSC when so specified) were delivered (suspended in 100 μL of 
standard cell culture medium) to each material granules tested; the final cell density was 106 cells 
per cell-containing construct for in vivo studies or 105 cells per construct for in vitro studies. 
Unseeded scaffolds served as controls. After 4 h of incubation at 37°C, the supernatant was 
discarded and the granules were embedded in a fibrin gel (Tissucol®; Baxter) prepared by mixing 
100 μL of fibrinogen (9 mg mL−1) with 5 μL of thrombin (100 UI mL−1) as previously described.37 
These cell-containing constructs were maintained in 2 mL of standard cell culture medium at 37°C 
overnight before use in experiments. 
In vivo studies  
Ten-week-old, female, nude mice were obtained from Janvier and handled according to the 
European Guidelines for Care and Use of Laboratory Animals (EEC Directives 86/609/CEE of 
24.11.1986). All experimental animal procedures conducted in the present study were approved by 
the Ethics Committee on Animal Research of the Lariboisiere/Villemin, Paris, France. The hBMSC-
containing constructs (n=7 per group for the HA/TCP, coral, and BG constructs; n=6 per group for 
both the HA/TCP-BG and coral-BG composite constructs) were subcutaneously implanted in mice as 
previously described.36 Briefly, each mouse was preoperatively given analgesics (0.4 mg of 
buprenorphine per kg animal weight; Axience), anesthetized by intraperitoneal injection of 100 mg 
kg−1 ketamine (Ketalar®; Virbach) and 10 mg kg−1 xylazine (Rompun® 2%; Bayer), and its skin was 
disinfected. Symmetrical incisions were made on the back of each mouse on both sides of the spine 
and subcutaneous pouches were created. The cell-containing constructs to be tested were inserted 
into each pouch (four constructs per mouse). The soft tissues at the implantation sites were then 
closed with interrupted nonresorbable sutures. Eight weeks postimplantation, the animals were 
sacrificed through injection of lethal doses of pentobarbital (Dolethal®; Vetoquinol). At that time, the 
constructs were retrieved en-bloc and fixed in 10% (v/v) phosphate-buffered formalin before analysis 
as described in the next section. 
For monitoring the implanted cell survival in vivo, special cell-containing constructs were prepared 
using LuchBMSC. Following implantation of these cell constructs, the mice were imaged twice a week 
during the 8-week postimplantation period as previously described.38 Briefly, the mice were 
anesthetized by inhaling isoflurane followed by local injection of 100 μL of D-luciferin (15 mg mL−1 in 
PBS) at each implantation site. The animals were then imaged using a bioluminescence imaging 
system (Ivis Lumina II®; Caliper Life Sciences). Standard regions of interest surrounding each implant 
were delineated on the bioluminescence images and the photon flux emitted by each construct was 
quantified using the Living Image® 3.1 software (Caliper Life Science). To compare cell survival in 
each construct tested, photon fluxes were normalized with respect to the signal acquired at the 
beginning (day 1) of the respective in vivo experiment. 
Histology and immunohistochemistry  
Six out of seven retrieved constructs for each material tested were processed for undecalcified 
histology. After fixation, the explanted samples were rinsed in water, dehydrated in ethanol, cleared 
in xylene, and embedded in methyl methacrylate as previously described.29 Each sample was then 
cut into either six or seven sections (each 500 μm thick) using a diamond circular saw (Leica 1600; 
Leica). Each such specimen section was then grounded to a thickness of 100 μm and stained using 
Stevenel's blue and Van Gieson Picrofuchsin red for subsequent histological analysis. Three 
nonadjacent sections from each specimen were selected for histomorphometrical analysis. 
Histological examination was performed using an optical microscope (Nikon Eclipse TE2000-U; Nikon 
France) equipped with a numeric camera (DXM1200F; Nikon). Bone was quantified using the NIS-
Elements BR 2.30 software (Nikon). The surface area of bone (stained in red) was measured in each 
specimen section and normalized over the whole surface area delineated around each section. 
The remaining seventh retrieved construct (from the HA/TCP, coral, and BG construct groups) was 
fixed in 4% paraformaldehyde (pH 7.4) for 36 h, decalcified in Decalcifier II (Surgipath) at 4°C for 48 h, 
and embedded in paraffin. Sequential sections were processed for human beta-microglobulin (a 
membrane protein that enables tracking human cells) immunodetection. Briefly, tissue sections were 
pretreated in a proteolytic enzyme solution (Dako) at 37°C for 20 min. Cell membranes were 
permeabilized using 0.3% Triton X-100 for 15 min; the endogenous peroxidase activity was inhibited 
by addition of peroxidase block (Kit Envision+; Dako), and the nonspecific binding sites were blocked 
using Protein Block (Dako). The tissue sections thus prepared were sequentially incubated in the 
primary antibody, polyclonal rabbit anti-beta-2-microglobulin (1/1000; Novocastra) for 1 h, incubated 
with the Labelled Polymer-HRP Anti-Rabbit antibody (Envision+ Kit, K4011; Dako) for 30 min, and 
visualized using the DAB chromogen (Envision+ Kit, K4011; Dako) for 5 min. 
In vitro hBMSC adhesion and proliferation onto material scaffolds  
Cell adhesion was assessed using SEM. Briefly, hBMSC were seeded onto granules (103 cells per mg 
of material granules) and cultured under standard cell culture conditions for 24 h. At that time, the 
specimens were washed once with cacodylate 0.1 M (pH 7.4) and fixed in 2.5% glutaraldehyde (in 
cacodylate 0.1 M; pH7.4) at 4°C for 1 h. After two washings in cacodylate, the specimens were 
dehydrated in successively increasing concentrations of alcohol (from 30% to 100%). For SEM 
examination, the specimens of interest were treated in hexamethylsilazane baths (HMDS; Delta 
microscopy), dried overnight, and coated using a sputter coater equipped with a gold target 
(EMSCOPE SC 500; Elexience). These specimens were examined using a 505 Philips SEM (FEI 
Company) at 10 keV. 
Proliferation of hBMSC onto the material granules tested was monitored in vitro both in two-
dimensional (2D) (i.e., granules deposited on the bottom of a tissue culture polystyrene [TCPS] dish) 
and in 3D (i.e., granules dispersed within fibrin gel constructs). Cell proliferation in 2D conditions was 
determined by DNA quantification. Specifically, aliquots of 40 mg of material granules were 
transferred in each well of 48-well plates; hBMSC (3×104 cells) in a standard cell culture medium 
were seeded. At different times of culture (specifically, at 0, 14, 21, and 28 days), cells were lysed 
using the lysis buffer (1 mM MgCl2, 0.1 M Na2CO3, 0.1 M NaHCO3, 0.1% Triton X100 [v/v]; pH 10.2) 
and freeze/thawed three times (to disrupt the cell membranes). Cell DNA content was determined 
using the CyQuant® cell proliferation assay kit (Molecular Probes) according to the manufacturer's 
instructions. Cell proliferation in the 3D constructs was assessed using bioluminescent (BLI) imaging. 
For this purpose, the cell constructs were prepared using LuchBMSC (105 cells per construct), 
transferred into 24-well plates, and cultured in the standard cell culture medium for the prescribed 
time periods (up to 28 days). The BLI signal from each cell-containing construct was determined 
nondestructively three times a week by adding D-luciferin (at a final concentration of 300 ng mL−1 
PBS) into each cell construct-containing well; BLI images were acquired using a bioluminescence 
imaging system. To compare the time course of cell proliferation in each construct tested, photon 
fluxes were normalized with respect to the signal acquired at the beginning (day 1) of the respective 
cell culture period. 
Determination of the osteogenic differentiation of hBMSC in vitro  
In the present study, to assess the osteogenic differentiation of hBMSC cultured onto the material 
granules of interest, cells were seeded at a density of 3×103 cells cm2 in each well of six-well plates 
in the presence of 40 mg of granules of each one of the three materials tested. These cells were 
cultured in the osteogenic medium, which is the standard cell culture medium containing 10−7 M 
dexamethasone, 150 μM ascorbic acid-2 phosphate, and 2 mM β-glycerophosphate (all chemicals 
from Sigma-Aldrich), for up to 28 days. The supernatant medium was replaced every 2–3 days for the 
duration of the study. To assess the impact of the cell culture medium pH on the osteogenic 
differentiation of hBMSC, the cells (3×103 cells cm2) were cultured in the osteogenic medium 
buffered with 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) the pH adjusted at 
either 7.47, 7.90, 8.27, 8.85 or 9.37, and cultured in a humidified, 37°C, atmospheric air environment 
(in the absence of supplementary CO2 inlet) for up to 28 days. Cells in the culture medium buffered 
using the physiological CO2/HCO3 buffer system at pH 7.54 were the respective controls. In this 
experiment, the initial pH value (pHini) of the osteogenic culture medium (which was added fresh to 
the cells) and the final pH value (pHfin) of the supernatant cell culture medium (which was removed 
from the cells) were specifically checked at each culture medium change (i.e., every 2–3 days) during 
the cell culture period. 
At the end of each prescribed cell culture period, the osteogenic differentiation of these cells was 
assessed by quantifying expression of a panel of osteoblastic markers (as described in the next 
section) as well as by determination of the activity of alkaline phosphatase (ALP) and mineralization. 
The ALP activity was determined both by staining the cell cultures in situ using a commercially 
available kit according to the manufacturer's (Sigma-Aldrich) instructions and by quantifying the ALP 
activity in cell lysates as previously described.39 The presence of calcium-containing deposits in the 
ECM was detected by staining the cells using the Alizarin red (AR) method. All these experiments 
were performed in triplicate and repeated at two separate times. 
Quantitative gene expression analysis by real-time polymerase chain reaction  
Total ribonucleic acid (RNA) was extracted from hBMSC using the NucleoSpin RNA II kit (Macherey-
Nagel). The RNA concentration was measured using a NanoDrop ND-1000 (LabTech) 
spectrophotometer. One microgram of extracted RNA was used as template for single-strand cDNA 
synthesis using the SuperScriptTM II Reverse transcriptase Kit (Invitrogen). Five microliters of cDNA 
(diluted at a 1:20 ratio) was used to program amplifications through real-time polymerase chain 
reaction (PCR) using specific primers of genes encoding for runt-related transcription factor 2 
(RUNX2) (Hs00231692_m1), collagen type 1 α1 (Col1a1) (Hs00164004_m1), osteopontin (OPN) 
(Hs00960942_m1), osteocalcin (OC) (Hs00609452_g1), and for bone sialoprotein (BSP) 
(Hs00173720_m1) (all from Applied Biosystems, Inc.), combined with TaqMan Universal PCR Master 
Mix using the MyiQ™ Single-Color Real-Time PCR thermocycler (Bio-Rad Laboratories) according to 
the protocol described previously.40 All samples, including specimens from experiments and 
standards (n=3 for each condition), were run in triplicate and in parallel. Data were analyzed using 
the iCycler IQ software (Biorad) and were compared by the ΔΔCt method. The results from hBMSC 
cultured onto the material granules tested in the present study were normalized to the amount of 
18S transcript and were expressed relative to the results obtained from cells at day 0. The results 
from hBMSC cultured at different pH values were normalized to the amount of 18S transcript, and 
were expressed relative to the results obtained from hBMSC cultured in the nonosteogenic medium 
for the same time period. 
pH in the 3D constructs  
To determine the pH in the core environment of the material constructs containing the tested 
granules (without cells), a microelectrode (PerpHecT®ROSS; Thermo Scientific) was inserted in the 
material granules before the fibrin gelation. After gelation, the constructs were maintained in 2 mL of 
weakly buffered solution, specifically, PBS (1 mM sodium phosphate at pH 7.4) to minimize the 
buffering impact on the pH determination. The pH was monitored at room temperature for 24 
consecutive hours. The global pH of the constructs seeded with 106 hBMSC was also determined 
before (day 0) and after implantation in mice for either 3 or 7 days. After animal sacrifice, the cell 
constructs were excised, chopped into small pieces, and transferred in 1 mL of 1 mM PBS solution 
(pH 7.4). After mixing, the pH of each such solution was measured using a calibrated pH meter (Star 
Orion). 
Statistical analyses  
Numerical results are reported as mean±standard deviation. The nonparametric Mann–Whitney U-
test was used to analyze data from two independent conditions. When comparing data of more than 
two conditions, the Kruskal–Wallis one-way analysis test was used. Quantitative data from in vivo BLI 
signals were analyzed using the two-way analysis of variance. For all analyses, differences were 
considered to be statistically significant at p<0.05. 
Results 
Physical properties of the granule surfaces  
Visualization of the three materials tested using SEM enabled analysis of their macro- and 
microstructure (Fig. 1A–F). The HA/TCP granules exhibited a round shape and rough surface texture 
(Fig. 1A). At higher magnification (Fig. 1B), the round HA/TCP granules contained dense aggregates 
(1–10 μm) of round elemental particles/grains of the 100 nm size. The shapeless aggregates, which 
formed agglomerates, were lightly bonded in contrast to the elemental grains that were highly 
sintered (i.e., more strongly bonded). The coral granules had branching shapes (Fig. 1C). At higher 
magnification (Fig. 1D), the coral granules exhibited a rough and granular surface as that observed 
with HA/TCP granules. The main coral granules were composed of dense aggregates of small, round, 
and acicular particles a few nanometers in size (Fig. 1D). The coral appeared denser than the HA/TCP 
granules (Fig 1B). The BG granules, preconditioned with SBF, displayed sharp angular shapes (Fig. 1E). 
At higher magnification (Fig. 1F), the cHA layer coating the surface of the BG granules contained 
round aggregates ranging between 200 nm and 1 μm in diameter, which were composed of smaller 
particles of about 100 nm in diameter. The specific surface area of the coral, HA/TCP, and BG 
granules was 0.06, 0.33, and 1.09 m2g−1, respectively. Altogether, these observations indicated that, 
at the nanometer scale, the surface topography and roughness of the three materials tested were 
different, but at the hBMSC scale (20–50 μm), they were similar. 
 
FIG. 1.  Scanning electron micrographs of HA/TCP (A, B), coral (C, D), and BG (E, F) granules at low 
(A, C, E) and high (B, D, F) magnification. BG, bioactive glass; HA/TCP, hydroxyapatite/tricalcium 
phosphate. 
 
In vivo bone formation by hBMSC contained in the constructs tested  
De novo bone formation was assessed when hBMSC-containing constructs (prepared with either 
HA/TCP, coral, BG or composite of either HA/TCP:BG or coral:BG) were implanted ectopically in a 
mouse model. After 8 weeks of subcutaneous implantation, there was no bone formation in 
conjunction with material scaffolds without cells; these scaffolds, however, were infiltrated with 
fibrous tissue (data not shown). At the same time point, new bone tissue was observed both in the 
hBMSC-containing HA/TCP and coral constructs as shown in the representative histology results from 
such explants (Fig. 2A). The osteogenic outcome of hBMSC contained within the tested coral- and 
HA/TCP- implants was similar and was characterized by high prevalence of bone formation and by 
similar amount of deposited new bone tissue (Fig. 2B). In contrast, no bone tissue was detected in 
any of the hBMSC-containing BG constructs (Fig. 2A, B). When hBMSC were contained within the 
50:50 composites of either HA/TCP:BG or coral:BG constructs, newly formed bone was found at the 
periphery of the constructs as well as consistently in contact with the coral and HA/TCP material 
surfaces. Very small amount of bone tissue (<0.2% compared with 4.2% and 3.8% for HA/TCP and 
coral cell-containing constructs, respectively) was observed (Fig. 2A) and the prevalence of bone 
formation was reduced (Fig. 2B) in composite constructs. Altogether, the present results provided 
evidence that, in contrast to the HA/TCP and coral materials tested, hBMSC cultured on BG did not 
induce bone formation; moreover, the presence of BG in the composite constructs tested had a 
negative effect on osteogenesis. 
 
FIG. 2.  Ectopic bone formation after 8 weeks of subcutaneous implantation of scaffolds containing 
hBMSC. (A) Representative, undecalcified, histological cross sections of hBMSC-containing constructs 
composed of either HA/TCP, coral, BG granules or composites of either HA/TCP:BG or coral: BG 
(50:50 w/w). Stains: Stevenel's blue and Van Gieson Picrofuchsin red. (B) Amount of new bone tissue 
determined by histomorphometric analysis. The frequency of bone formation per implant material 
tested is also indicated. *Material scaffold; the red color provided evidence for mineralized bone 
tissue. Arrows locate area of new bone formation in composites of HA/TCP or Coral:BG. hBMSC, 
human bone marrow-derived stromal cells. Color images available online at 
www.liebertpub.com/tea 
 
 
Viability of hBMSC onto the materials tested  
The issue of potential toxicity of BG on hBMSC was addressed. For this purpose, adhesion and 
proliferation of hBMSC on the material granules was determined. SEM examination at 24 h 
confirmed that the hBMSC adhered and spread in a similar fashion onto the three substrates tested 
(Fig. 3A). Cell proliferation was determined when hBMSC were cultured onto granules of each one of 
the three materials tested that had been placed on the bottom of individual wells of tissue culture 
dishes (Fig. 3B). DNA quantification at different time points over a 4-week period of culture provided 
evidence that, under these conditions, hBMSC proliferation was similar for hBMSC cultured on the 
three materials tested as well as on TCPS, the reference substrate (Fig. 3B). 
 
FIG. 3.  Viability of hBMSC onto material scaffolds either cultured in vitro (A–C) or implanted in vivo 
in nude mice (D, E). (A) In vitro hBMSC adhesion evaluated by scanning electronic microscopy 24 h 
postcell seeding. (B) In vitro cell proliferation assessed when hBMSC were cultured either directly on 
tissue culture polystyrene (TCPS; TPP®) alone or onto granules placed on the bottom of individual 
wells of TCPS dishes and determined by DNA quantification; (C) In vitro cell proliferation assessed 
when LuchBMSC were cultured within three-dimensional constructs (composed of material granules 
embedded in fibrin gel) and determined by BLI monitoring. Photon fluxes (normalized to those 
obtained at day 1 after cell seeding) were plotted versus the number of days of cell culture. p<0.001 
(two-way analysis of variance [ANOVA]); #p<0.05 for the BG constructs compared with the other two 
material constructs tested (Mann–Whitney test). (D) In vivo cell viability was determined by 
monitoring BLI over 58 days of implantation: photon fluxes (normalized to those obtained at day 1 
postimplantation) were plotted versus duration of implantation; p<0.001 (two-way ANOVA); #p<0.05 
(Mann–Whitney test) for the BG constructs compared with the other two material constructs. (E) 
hBMSC, still present in the constructs explanted 2 months postimplantation, were detected on 
paraffin-treated sections following immunostaining against human β-2-microglobulin. *Scaffold 
material (either HA/TCP, coral, or BG); black arrow head indicates cells stained positive for human β-
2-microglobulin. BLI, bioluminescent. Color images available online at www.liebertpub.com/tea 
 
Cell viability was also assessed by determining hBMSC proliferation within 3D cell-containing 
constructs composed of either HA/TCP, coral, or BG granules embedded in the fibrin gel (Fig. 3C). 
Proliferation of hBMSC (previously labeled with the luciferase gene reporter) was monitored 
nondestructively in each construct using bioluminescence imaging. Similar profiles of LuchBMSC 
proliferation kinetics were observed for the three types of constructs of interest to the present study. 
Compared with the initial seeding, the number of cells increased by 2- to 3-fold after 15 days of 
culture; the highest cell proliferation was observed in the BG constructs (3.4-fold at day 14; p<0.05 
compared with the other two material constructs) (Fig. 3C). Furthermore, hBMSC survival was also 
assessed in vivo after subcutaneous implantation of the cell-containing constructs in nude mice for 2 
months (Fig. 3D). For the cases tested, the number of viable implanted cells decreased over this time 
period. The decrease in cell survival was significantly (p<0.05) slower in the BG constructs compared 
with that obtained on the HA/TCP and coral ones up to 14 days postimplantation. After that time 
point, a steady decrease in the luminescence signal from all implanted cell-containing constructs was 
observed (Fig. 3D). As a result, only 10% to 30% of the initial cell numbers remained for all constructs 
tested at 8 weeks postimplantation. These results indicated a loss of viable hBMSC, which occurred 
upon implantation independent of the type of material tested; more importantly, the implanted 
hBMSC did not die faster in the BG than in the other two material constructs. 
Immunostaining of human β-2-microglobulin enabled visualization of the hBMSC still present in 
sections of constructs explanted 8 weeks postimplantation (Fig. 3E). Human β-2-microglobulin-
positive cells were detected at different locations in the tissue surrounding the granules, but were 
most frequently found on the material surface of all three types of constructs tested (Fig. 3E). These 
results confirmed the cytocompatibility of the three materials tested over the 8-week period of 
implantation. It should be noted that hBMSC were detected not only in fibroblastic connective tissue, 
but also in newly formed bone as well as around blood vessels in the HA/TCP- and coral-cell-
containing constructs (data not shown). In contrast, positive-stained hBMSC were only detected in 
the fibroblastic connective tissue in the BG-cell-containing constructs. Overall, cell spreading on the 
granule surfaces (Fig. 3A), cell proliferation in vitro (Fig. 3B, C), as well as the scaffold material 
cytocompatibility in vivo (Fig. 3D, E) provided evidence that the observed absence of de novo bone 
formation in the hBMSC-containing BG constructs is not the result of lack of cytocompatibility of the 
BG material. 
Osteogenic differentiation of hBMSC cultured onto the materials tested  
Another aspect addressed in the present study was the potential for osteogenic differentiation of 
hBMSC cultured on BG granules as compared with results obtained on either the HA/TCP or coral 
substrates. For this purpose, the ALP activity of hBMSC cultured in the osteogenic differentiation 
medium on the three material granules tested was assessed. The ALP activity of hBMSC cultured on 
either HA/TCP or coral granules peaked at 14 days (Fig. 4A), indicating osteogenic differentiation of 
hBMSC on these materials. HBMSC exhibited a significantly (p<0.05) greater ALP activity on HA/TCP 
and coral than on BG granules at 14 and 21 days of culture (Fig. 4A). In addition, the ALP activity of 
hBMSC cultured on TCPS (reference substrate) was three-, three-, and sevenfold higher than that 
obtained when the cells were cultured onto the HA/TCP, coral, and BG granules, respectively (data 
not shown). The results were confirmed by the enhanced positive ALP staining of cells cultured on 
HA/TCP and on coral granules compared with BG ones for 14 and 28 days (Fig. 4B). 
 
FIG. 4.  Osteogenic differentiation of hBMSC cultured onto granules of HA/TCP, coral, and BG. (A) 
Kinetics of the ALP activity expressed by hBMSC; p<0.001 (two-way ANOVA) and #p<0.05 (Mann–
Whitney test) compared with values obtained with either HA/TCP or coral granules at the same time 
point. (B) hBMSC stained in situ for ALP after 0, 14, and 28 days of cell culture. ALP, alkaline 
phosphatase. Color images available online at www.liebertpub.com/tea 
 
A panel of genes indicative of osteogenic differentiation was also investigated using quantitative 
polymerase chain reaction (qPCR) (Supplementary Fig. S1; Supplementary Data are available online 
at www.liebertpub.com/tea). Expressions of all markers (specifically, RUNX2, Osterix, Col1a1, OC, 
and OPN) tested by hBMSC were similar when cultured on the three types of granules at both 7 and 
14 days of culture. 
Determination of the pH in the material constructs tested  
The pH in the core environment of the cell-free BG constructs was determined to assess the 
alkalinization induced by the material itself (in the absence of cell-mediated acidosis). Starting from 
7.4, the pH increased during the first hours postgelation and reached a plateau at later (>10 h) times 
(Fig. 5A). At 24 h postgelation, the pH values in the HA/TCP-, coral-, and BG-containing constructs 
were 8.6, 8.3, and 9.1±0.1, respectively. The pH of the BG constructs was 0.5 and 0.8 U more alkaline 
than the pH determined in the HA/TCP and coral constructs, respectively. 
 
 
FIG. 5.  pH determination within the material constructs. (A) Time course of pH values at the core of 
the material granule constructs (without cells) using a microelectrode inserted before fibrin gelation. 
(B) pH measurements from cell constructs before (day 0) and after in vivo subcutaneous implantation 
for either 3 or 7 days. (C) In vitro pH determination as a function of the ratio (from 0% to 100% in 
weight) of BG granules in either HA/TCP: BG or coral: BG cell-containing composite constructs. 
#p<0.05 (Mann–Whitney test) compared with values obtained with either HA/TCP or coral materials 
at the same time point. 
Because these cell-free conditions did not reflect those of the cell-containing constructs implanted in 
vivo, the pH of constructs seeded with 106 cells was also measured before their implantation (day 0) 
and immediately upon their removal from mice after 3 and 7 days of implantation. The pH in the cell-
containing BG constructs was 8.03±0.03 at day 0 and remained similar at the prescribed 
postimplantation time points (Fig. 5B). The pH value in these BG constructs was 0.4–0.5 U more 
alkaline (p<0.05) than that measured in the other two types of cell-containing material constructs. 
The pH from both cell-containing HA/TCP:BG and coral:BG composite constructs that contained 
increasing ratios of BG was also measured in vitro. The data showed a strong correlation (r2=0.88 
and 0.99 for the HA/TCP:BG and the coral: BG composites, respectively) between the pH and the 
content of BG in the scaffolds of cell-containing constructs (Fig. 5C). Altogether, these results 
confirmed the alkalinization of the environment of the BG cell-containing constructs. 
Osteogenic differentiation of hBMSC as a function of the pH of the cell culture medium  
The effect of the pH of the cell culture medium (ranging from 7.47 to 9.37 using the HEPES buffer) on 
both the proliferation and the osteoblastic differentiation potential of hBMSC was also investigated. 
It is worth noting that a decrease of both pHini and pHfin values ranging from 0.1 U of pH, for the 
lowest pHini (7.47), to 0.8 U for the highest pHini (9.37) value was noticed after 2–3 days of cell 
culture (Table in Fig. 6D). 
 
 
 
FIG. 6.  Osteogenic differentiation of hBMSC as a function of the pH of the culture medium. (A) 
Proliferation of hBMSC cultured in buffered osteogenic medium either using a standard CO2/HCO3 
system or adjusted to increasing alkaline pH values using 25 mM HEPES; p<0.001 (two-way ANOVA) 
for the cell cultures at either pH 8.85 or 9.37; these results were compared with those obtained from 
cell cultures at other pH values (specifically, 7.47, 7.54, 7.90, and 8.27). (B) Gene expression of 
RUNX2, ALP, and BSP by hBMSC cultured in osteogenic medium (Os+); gene expression was 
normalized first to that of the respective 18S (internal standard), and then to results obtained when 
cells were cultured in the nonosteogenic culture medium (Os−); ap<0.05 compared with pH 7.47 Os+ 
group; bp<0.05 compared with pH 7.90 Os+ group; cp<0.05 compared with pH 8.27 Os+ group 
(Mann–Whitney tests). (C) Kinetics of the ALP activity expressed by hBMSC cultured in osteogenic 
medium; p<0.001 (two-way ANOVA) for the cell cultures performed at either pH 8.27 or 8.85 
compared with cultures at other pH (specifically, 7.47, 7.54, and 7.90). (D) ALP and Alizarin red (AR) 
in situ stainings of hBMSC. Average values of both the initial and final pH of the supernatant culture 
medium, which were determined at each medium change during the course of the experiment, are 
indicated in the Table included on this frame. BSP, bone sialoprotein; HEPES, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid; RUNX2, runt-related transcription factor 2. Color images available 
online at www.liebertpub.com/tea 
Under these conditions, DNA quantification provided evidence that hBMSC proliferation was 
unaffected at alkaline pH up to 8.27; there was no cell proliferation at pH 8.85 and the cells died at 
pH 9.37 (Fig. 6A). To assess the impact of the medium pH on the osteoblastic differentiation potential 
of hBMSC, a panel of genes indicative of osteogenic differentiation was investigated using qPCR (Fig. 
6B). hBMSC were cultured in the nonosteogenic medium as negative control. At either physiological 
pHini (7.47) or moderate alkaline pHini (≤7.90), expression of the osteoblastic (RUNX2, ALP, and BSP) 
markers was higher when the cells were cultured in osteogenic than in nonosteogenic media 
indicating osteogenic differentiation of the hBMSC in the range of these pH values (7.47≤pHini≤7.90). 
At higher (>7.90) pHini, gene expression of the three markers monitored dramatically decreased and 
reached similar, or even lower, levels of expression as the ones obtained when the cells were 
cultured in the nonosteogenic medium. 
The extent of both the ALP activity and mineralization of the hBMSC ECM was also strongly 
dependent on the pH of the cell culture medium (Fig. 6C, D). The highest level of ALP activity 
occurred at day 14 when the cells were cultured at pHini 7.47 (Fig. 6C). Similar results were obtained 
when the cell culture medium was buffered (using a CO2/HCO3 system) either at pHini 7.54 or at a 
moderate alkaline pHini (7.90) level (Fig. 6C). At pHini 8.27, the ALP activity significantly decreased, 
while at pHini 8.85, minimal ALP production occurred at a later time, specifically, at 28 days of 
culture (Fig. 6C). ALP staining of cells confirmed these results (Fig. 6D). Mineralization of the hBMSC 
ECM occurred only at physiologic pHini (pHini<7.54) and was visualized using AR staining (Fig. 6D). It 
is worth noting, however, that the cell culture medium buffered with HEPES affected the 
mineralization process; at similar pHini, the kinetics of mineral accumulation was delayed and the 
amount of mineral deposited was lower in the HEPES-buffered system compared with the results 
obtained using the CO2/HCO3 system (Fig. 6D). 
These results provided evidence that the alkaline pH (specifically, pH>7.9) affected adversely both 
the hBMSC osteogenic differentiation and, more strongly, the mineralization process of the ECM. 
Interestingly, while hBMSC proliferation (Fig. 6A) was not affected at pH 8.27 (the pH value in the 
vicinity of the BG granules in the cell constructs tested), their osteogenic differentiation was inhibited 
(Fig. 6B, C). 
 
Discussion 
The present study is the first to address the impact of pH in the microenvironment of bone TE 
constructs on osteogenesis. The results provided evidence that constructs of hBMSC contained in a 
material, specifically, BG, induces alkalinization of the microenvironment did not promote de novo 
bone formation; in contrast, cell-containing constructs prepared with either HA/TCP or coral, the two 
other materials tested, did not change significantly the microenvironment pH, but consistently 
induced bone tissue. 
BG is well known to alkalinize surrounding fluids22,23 due to the consumption of protons (H3O+ 
ions) during the ion exchange reactions between the glass network and the aqueous media.41 In the 
present study, the pH within the cell-free BG constructs was around 9.0 and decreased to 8.0 in the 
cell-containing BG constructs both before and after implantation in mice. This decrease in pH value, 
although without reaching the physiological value (7.4), is explained by the acidosis that accompanies 
cell metabolism. In addition, the strong correlation established between the pH and the proportion 
(in weight) of BG granules within the cell-containing composite constructs confirmed the effect of BG 
material in the alkalization process. 
The hBMSC-mediated osteogenic potential was assessed in vivo after subcutaneous implantation of 
the cell-containing material constructs in mice. This is a standard in vivo model that excludes and/or 
reduces the effects of endogenous bone-forming cells and of bone-stimulating mechanotransduction 
on the process of new bone formation.13,42 Interestingly, the in vivo results evidenced that the 
implanted 50:50 composites of both HA/TCP:BG and coral:BG constructs, whose pH was around 7.8, 
had very little amount of bone tissue after 8 weeks postimplantation. Altogether, these results 
evidenced a correlation between loss of the bone forming potential of the cell-containing constructs 
and the degree of alkalinization within these constructs: osteogenesis decreased 20–30-fold when 
the pH rose from 7.5 to 7.8, and it was totally inhibited when the pH reached 8. 
BG and glass ceramics are widely used in bone repair applications and are considered appropriate 
materials for bone TE applications.43 However, information regarding the performance of BG as 
scaffolds for the delivery of osteocompetent cells in TE applications has been lacking. The absence of 
osteoinductivity observed with BG-containing constructs in the present study is in agreement with 
the results from other groups who reported that various formulations of silicate glasses (such as 45S5 
BG, 13–93 BG, and BG/polymer composites) seeded with stem/precursor cells promoted abundant 
fibrous tissue infiltration upon implantation in ectopic sites in rodents. These studies reported the 
presence of sporadic osteoid or bone-like tissue within constructs, but none of them evidenced bone 
tissue formation unequivocally.44–46 
In the present study, histological analysis of the composite constructs tested showed that the bone 
tissue was located onto the surface of either HA/TCP or coral, but not on BG. Such observation 
suggests that the reduced osteogenic potential in BG-containing constructs in vivo was closely 
related to the BG material surface and/or to its local microenvironment. 
In respect to the physical properties of the material surface, the SEM images showed that, at the 
scale of hBMSC, that is, 20–50 μm, the topography, roughness, and available material surface for cell 
attachment were equivalent for the three materials tested. In respect to the material 
microenvironment, it is well documented that dissolution of BG material mediates the release of ions 
such as Na+, Ca2+, and Si products (presumably in the form of silicic acid Si(OH)4) into the 
surrounding aqueous media; continuous hydrolysis of silica groups results in increased local pH.19 
The impact of both material surface physicochemistry and dissolution products (released in the 
microenvironment) on the hBMSC cytocompatibility was evaluated in vitro and in vivo. In vitro, both 
adhesion and proliferation of hBMSC cultured directly onto the BG surface were not affected 
compared with the other materials tested. When hBMSC were seeded within 3D BG constructs, and, 
therefore, exposed locally to this material dissolution product, cell viability was even higher 
compared with respective results obtained from the other two types of material constructs tested 
both in vitro and in vivo. Implanted hBMSC still remained on the surface of all types of materials 
tested 8 weeks postimplantation. 
Among the hypotheses that could explain the observed higher viability of hBMSC in BG constructs is 
the possible impact of BG on the metabolic activity of cells. Indeed, Silver et al. reported that BG 
enhanced glycolysis in osteoblasts in vitro and, thus, their cellular ATP production; those authors 
stated that these metabolic effects are most likely consequences of external and internal 
alkalinization in the cell milieu.22 If BG has similar effects on the hBMSC metabolism in vivo, as it 
does on osteoblasts in vitro,22 stimulation of ATP generation may be beneficial for cell viability inside 
the TE constructs tested. All in all, these data confirmed that BG materials are cytocompatible both in 
vitro and in vivo in agreement with previous studies.47,48 
On one hand, viability of hBMSC was not affected by BG, on the other hand, however, its potential 
for osteogenic differentiation was diminished in vitro. Such result obtained in vitro, as well as lack of 
osteogenic evidence in the cell-containing BG constructs in vivo, seems to be affected by the ionic 
exchange occurring at the surface of the material and/or by its side effects (such as pH changes). This 
hypothesis is strengthened by the minimal bone formation obtained from the 50:50 composites of 
both HA/TCP:BG and coral:BG constructs: osteogenesis decreased 20–30-fold when half (in weight) 
of either the HA/TCP or coral granules was replaced by BG granules; this result suggests that one or 
several diffusible chemicals, such as ion complexes (concomitant to pH changes), impede the hBMSC-
mediated osteogenesis. 
The aforementioned results are in striking contrast with the numerous literature reports regarding 
the beneficial effects of products released from BG (without taking into account concomitant pH 
changes) on various functions (such as proliferation, differentiation, ECM production, mineralization, 
and even angiogenesis) of human progenitors pertinent to new tissue formation.49–52 Especially, Si 
products were reported to enhance osteogenic markers in osteoprogenitor cells.53,54 Nevertheless, 
within the microenvironment of the BG constructs in vivo, cells may have been exposed locally to 
higher concentrations of Si products in the present study than those used in the published studies. 
Thus, one cannot exclude that release of ions/species (such as Na+, Ca2+, or more particularly 
Si(OH)4) from the BG granules into their microenvironment in the present study, may have 
contributed to the inhibition of bone tissue formation in vivo. 
The release of Si products from the BG material and the subsequent alkalinization of the surrounding 
medium are two chemical events that could not be separated in the present study because they are 
closely interlinked.19 However, the observed considerable (0.5 U) rise in the pH of the BG constructs 
(compared with the other two types of material constructs tested) raised questions regarding how 
the biological, in particular osteogenic, responses of hBMSC were affected in an alkaline milieu. It 
should be noted that alkalinization of the external medium was likely accompanied by a shift in the 
intracellular pH (pHint) in the same direction. However, the magnitude of change in the pHint is 
usually smaller than that in the external/extracellular pH (pHext) because of the control mechanisms 
(such as ion-transport systems) in eukaryotic cells.22,55 
The present results provided evidence that the in vitro hBMSC proliferation and osteogenic 
differentiation were not significantly affected at moderate alkaline pHext (up to 7.90), but were 
dramatically inhibited when the pHext increased further. Formation of mineralized nodules in the 
ECM of hBMSC proved more sensitive to the pHext since it was fully inhibited at alkaline (>7.54) 
pHext values. Most importantly, these findings indicated that there is a pHext range (specifically, 7.9–
8.27) at which hBMSC proliferation was not affected, but the osteogenic differentiation of these cells 
was inhibited. Such pHext range encompassed the one determined in the cell-containing BG granules 
(pHext ∼8) and could not only explain the observed proliferation of hBMSC in BG constructs in vitro 
and the cell viability in vivo, but also the absence of bone tissue formation in vivo. 
The effect of the pH of the tissue microenvironment on bone mineralization and repair has been 
reported previously.56–58 During the early healing phase in bone, Chakkalakal et al. determined that 
the tissue pH was lower than the physiologic (7.4) pH; when subsequently this pH increased to more 
alkaline values (specifically, to pH 7.56), it was accompanied by mineral deposition.25 On a cellular 
level, during metabolic acidosis, osteoblast functions decline, whereas during metabolic alkalosis, 
osteoblast functions (specifically, cell viability, ALP activity, and mineral deposition) increase.10,26–
28 With respect to bone TE using hBMSC, Kohn et al. reported that short-term (specifically, 48 h) 
exposure of hBMSC at decreasing (specifically, from 7.8 to ≤6.5) pH led to the decrease of osteogenic 
phenotype markers, specifically, ALP activity and collagen synthesis.59 Some of the aforementioned 
studies, however, reported a decrease of the osteoblastic activity at pH around 7.8,27,60 but have 
not tested a pH range that encompasses the excessive alkalosis (pH ∼8) observed in the 
microenvironment of the cell-containing BG constructs tested in the present study. Therefore, it is 
possible that the high local alkalinization induced by the BG constructs had adverse effects on the 
osteogenic differentiation of stem cells in contrast to the beneficial effects obtained with moderate 
alkalosis; in fact, such a condition was deleterious to hBMSC metabolism and function in vitro and, 
therefore, likely to their bone formation ability in vivo. 
In conclusion, the results of the present study evidenced a close relationship between inhibition of 
the hBMSC-mediated osteogenesis observed in vivo and the local alkalinization within the TE 
constructs tested. Excessive alkalinization in the TE construct microenvironment (resulting, for 
example, from material degradation) affected adversely the osteogenic differentiation of 
osteoprogenitor cells and may have consequently inhibited the osteogenicity of the constructs in 
vivo. Thorough characterization and control of the local, engineered, extracellular environment 
(specifically, changes of pH) are critical issues, which must be addressed in the development of 
bioactive scaffolds for successful TE, bone-related applications. 
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